Collaborative
intelligence

to power your
pipeline

Collaborative
intelligence
to power
your pipeline

At DaltonTx, we are redefining how technology
powers drug discovery creating the intelligence
backbone behind tomorrows medicines.

At DaltonTx, we are redefining how
technology powers drug discovery
creating the intelligence backbone

behind tomorrows medicines.

The future of drug discovery runs on DaltonTx. Our AI-enabled platforms give

pharma, biotech, and CROs the infrastructure modern R&D can’t move forward 

without — transforming the economics, timelines, and outcomes of discovery.

Real business impact from AI requires much more than predictive models.
DaltonTx offers something fundamentally different: an adaptive intelligent system
that evolves with your science, integrates seamlessly into your workflows, and puts lasting capability in your hands. The result is technology that learns from every scientist, model, and experiment — getting smarter over time and delivering meaningful results.

The future of drug discovery runs on DaltonTx. Our AI-enabled platforms give

pharma, biotech, and CROs the infrastructure modern R&D can’t move forward 

without — transforming the economics, timelines,
and outcomes of discovery.


Real business impact from AI requires
much more than predictive models.

DaltonTx offers something fundamentally different: an adaptive intelligent system
that evolves with your science, integrates seamlessly into your workflows, and puts lasting capability in your hands. The result
is technology that learns from every scientist, model, and experiment — getting smarter over time and delivering meaningful results.

Secure

Cloud-native infrastructure designed to fit your environment
— and scale as your science advances.

Cloud-native infrastructure designed to fit your environment — and scale as your science advances.

Collaborative intelligence

Fusing your human expertise with machine intelligence 


to continuously improve your drug discovery.

Fusing your human expertise with machine intelligence to continuously improve your
drug discovery.

Adaptive

Technology that learns from every scientist, model, and experiment — getting smarter over time and guiding better decisions.​

Comprehensive

Covers the full discovery lifecycle— including data ingestion, 


model training, molecule generation, and experiment prioritisation.

Covers the full discovery lifecycle— including data ingestion, 

model training, molecule generation, and experiment prioritisation.

Purpose-built

AI cloud platform to create your own AI-enabled drug discovery capability for both biologics and small molecules.

Our Technology Platform

The intelligence engine to power your discovery

The intelligence engine to power your discovery

Our Science

The science to solve your
toughest challenges

Built by scientists, for scientists — DaltonTx combines software
engineering, machine learning, and deep drug discovery expertise 


to address the most complex problems in modern R&D.

- Proven track record across small molecules and biologics


- Breakthrough performance on the hardest discovery challenges


- A scientific team rooted in academic excellence (University of Oxford) 

 and decades of real-world industry experience

Built by scientists, for scientists — DaltonTx combines software engineering, machine learning, and deep drug discovery expertise 


to address the most complex problems in modern R&D.

- Proven track record across small molecules and biologics


- Breakthrough performance on the hardest discovery challenges


- A scientific team rooted in academic excellence (University of Oxford) and decades of real-world industry experience

  • redalpine

  • IQ Capital

  • SEEDCAMP

  • redalpine

  • IQ Capital

  • SEEDCAMP

Our Investors & Partnerships

Our Investors &
Partnerships

Backed by vision. Built for impact.

Backed by vision.
Built for impact.

DaltonTx is proud to partner with investors and collaborators who share our belief in transforming discovery with applied intelligence.

DaltonTx is proud to partner with investors

and collaborators who share our belief in transforming discovery with applied intelligence.